phase 1 study

phase 1 study

See Phase study.
References in periodicals archive ?
We are now focusing our efforts on the oral formulation of Endoxifen and are developing a modified-release oral tablet which is being tested in a Phase 1 study and that we plan to use in a Phase 2 study to reduce MBD.
M2 PHARMA-July 19, 2018-RiMO Therapeutics Enrolls First Patient in Phase 1 Study of RiMO-301 With Radiation in Advanced Tumors
M2 EQUITYBITES-September 27, 2012-BioMarin Pharmaceutical Inc updates results from Phase 1 study of BMN-111 for achondroplasia(C)2012 M2 COMMUNICATIONS http://www.m2.com
"Our recently completed Phase 1 study demonstrated that OGX-011 prevents increases in clusterin expression induced by hormone ablation therapy," said Dr.
In a phase 1 study, researchers usually expose only a handful of volunteers--sometimes not more than 10, and rarely more than 80--to the new therapy.
In the Phase 1 study, the duration of wound closure on two patients following 100% wound closure as of the last follow up was 184 days and 174 days.
M2 PHARMA-September 27, 2012-BioMarin Pharmaceutical Inc updates results from Phase 1 study of BMN-111 for achondroplasia(C)2012 M2 COMMUNICATIONS
M2 EQUITYBITES-February 17, 2012-BioMarin Pharmaceutical Inc initiates Phase 1 study of BMN-111 in achondroplasia patients(C)2012 M2 COMMUNICATIONS http://www.m2.com
In 1998, Angiotech initiated the Phase 1 study of patients between 21 to 75 years of age who presented with Class I to III of RA severity and have failed treatment with at least one disease-modifying anti-rheumatic drug (DMARD), such as methotrexate.
In June, UNITY announced results from its first-in-human Phase 1 study of UBX0101 in patients with moderate-to-severe OA of the knee.
The primary objective of this Phase 1 study was to assess the safety and tolerability of SPI-1620 administered to patients with recurrent or progressive carcinoma who have failed all standard therapy.
The investigator-sponsored Phase 1 study is designed to assess the safety of AVR-RD-01 in up to six patients with Fabry disease who have been treated with standard of care enzyme replacement therapy for at least six months prior to receiving AVR-RD-01.